Related Experiment Videos
Immunopathology of interstitial cystitis
J W Said1, R Van de Velde, L Gillespie
1Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, California.
Summary
Chronic interstitial cystitis (IC) shows two main patterns: widespread immunoglobulin A (IgA) and fibrinogen staining, or vascular damage with immune complexes. These findings may guide IC prognosis and treatment.
Area of Science:
- Urology
- Immunopathology
- Cell Biology
Background:
- Chronic interstitial cystitis (IC) is a debilitating bladder condition of unknown etiology.
- Previous research has not clearly defined distinct pathological patterns in IC.
- Understanding the underlying mechanisms is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the histologic, ultrastructural, and immunofluorescence findings in bladder biopsies from patients with IC.
- To identify distinct pathological patterns associated with interstitial cystitis.
- To explore potential implications for prognosis and therapeutic strategies.
Main Methods:
- Analysis of cystoscopically directed bladder biopsies from 308 patients with IC.
- Histologic examination, immunofluorescence microscopy, and electron microscopy were employed.
- Staining for immunoglobulins (IgA, IgM, IgE), C3, and fibrinogen was performed.
Main Results:
- The majority of IC patients exhibited strong urothelial IgA staining and fibrinogen deposition, indicating a generalized response to injury.
- A subgroup of patients showed evidence of vascular damage and immune complex disease (IgM, C3) in the lamina propria.
- IgE staining and mast cells were not prominent, suggesting a limited role in IC pathogenesis.
Conclusions:
- Two main reaction patterns in interstitial cystitis are identified: IgA/fibrinogen deposition and vascular/immune complex disease.
- These distinct patterns may have significant implications for predicting patient outcomes and tailoring treatment approaches.
- Further research is warranted to elucidate the specific causes and therapeutic targets for each IC subtype.